Clinical Trials
Several clinical trials are currently evaluating neurocognitive and psychiatric interventions, including cognitive behavioral therapy and telepsychiatric evaluation, for conditions such as COVID-19-related mental health impairment, insomnia, schizophrenia, and schizoaffective disorder. Categorized under non-applicable phase designations, these studies are sponsored primarily by academic medical centers and public healthcare authorities. Recruitment statuses across the investigations range from active recruitment to unknown status.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05231018 | Unknown status | COVID-19|Mental Health Impairment|Telemedicine |
Fondazione IRCCS Ca'' Granda Ospedale Maggiore Policlinico |
2020-10-28 | Not Applicable |
| NCT04653155 | Unknown status | Insomnia |
Hospital Authority Hong Kong |
2020-06-01 | Not Applicable |
| NCT04144231 | Recruiting | Insomnia|Schizophrenia|Schizoaffective Disorder |
Helsinki University Central Hospital|University of Helsinki|Finnish Institute for Health and Welfare|Finnish Institute of Occupational Health |
2019-12-19 | Not Applicable |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
Compliance for Clinical Use
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).